Neurocrine Biosciences Reports Expansion of Clinical Pipeline By: Benzinga via Benzinga December 10, 2014 at 08:02 AM EST Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that NBI-77860, a proprietary corticotropin releasing factor 1 (CRF) ... Read More >> Related Stocks: Neurocrine Bioscienc